- Home
- RGNX vs ITIC Comparison
RGNX vs ITIC Comparison
Compare RGNX & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- ITIC
- Stock Information
- Founded
- RGNX 2008
- ITIC 1972
- Country
- RGNX United States
- ITIC United States
- Employees
- RGNX N/A
- ITIC N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- ITIC Specialty Insurers
- Sector
- RGNX Health Care
- ITIC Finance
- Exchange
- RGNX Nasdaq
- ITIC Nasdaq
- Market Cap
- RGNX 387.0M
- ITIC 440.1M
- IPO Year
- RGNX 2015
- ITIC N/A
- Fundamental
- Price
- RGNX $9.49
- ITIC $196.51
- Analyst Decision
- RGNX Strong Buy
- ITIC
- Analyst Count
- RGNX 8
- ITIC 0
- Target Price
- RGNX $31.75
- ITIC N/A
- AVG Volume (30 Days)
- RGNX 1.3M
- ITIC 88.4K
- Earning Date
- RGNX 07-31-2025
- ITIC 08-05-2025
- Dividend Yield
- RGNX N/A
- ITIC 0.95%
- EPS Growth
- RGNX N/A
- ITIC 18.56
- EPS
- RGNX N/A
- ITIC 15.69
- Revenue
- RGNX $156,718,000.00
- ITIC $261,197,999.00
- Revenue This Year
- RGNX $313.52
- ITIC N/A
- Revenue Next Year
- RGNX N/A
- ITIC N/A
- P/E Ratio
- RGNX N/A
- ITIC $12.30
- Revenue Growth
- RGNX 80.70
- ITIC 15.27
- 52 Week Low
- RGNX $5.04
- ITIC $168.74
- 52 Week High
- RGNX $15.36
- ITIC $290.40
- Technical
- Relative Strength Index (RSI)
- RGNX 49.21
- ITIC 29.66
- Support Level
- RGNX $7.95
- ITIC $190.20
- Resistance Level
- RGNX $11.00
- ITIC $235.99
- Average True Range (ATR)
- RGNX 0.95
- ITIC 8.46
- MACD
- RGNX -0.10
- ITIC -5.16
- Stochastic Oscillator
- RGNX 28.52
- ITIC 10.20
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.